Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided by an increase in revenues.
First-quarter worldwide sales increased 9% year-over-year to $15.8 billion, mainly reflecting sustained growth across the oncology and vaccine portfolios.
The company reported a net profit of $4.76 billion or $1.87 per share for the March quarter, compared to $2.82 billion or $1.11 per share in the prior-year period. On an adjusted basis, earnings climbed to $2.07 per share in Q1 from $1.40 per share in the first quarter of 2023.
“Merck has begun 2024 with continuing momentum in our business. We are harnessing the power of innovation to advance our deep pipeline and are maximizing the impact of our broad commercial portfolio for the benefit of patients,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Halliburton (HAL) performed in Q1 2025
Halliburton Company (NYSE: HAL) reported its first quarter 2025 earnings results today. Total revenue was $5.4 billion compared to $5.8 billion in the same period a year ago. Net income
Key metrics from Kimberly-Clark’s (KMB) Q1 2025 earnings results
Kimberly-Clark Corporation (NYSE: KMB) reported its first quarter 2025 earnings results today. Net sales of $4.8 billion were 6% lower than the year-ago period. Organic sales decreased 1.6%. Net
LMT Earnings: A snapshot of Lockheed Martin’s Q1 2025 financial results
Lockheed Martin Corporation (NYSE: LMT) Tuesday reported an increase in sales and profit for the first quarter of 2025. The aerospace company reported net sales of $18.0 billion for the first
